Syantra Plans Summer Launch Of Onco-ID

Calgary startup Syantra plans to launch Onco-ID, a blood-based breast cancer screening test, in select Canada, US and Europe locations this summer, and will publish updated clinical-trial data around May. Onco-ID uses machine learning to detect immune-response gene-expression biomarker patterns rather than ctDNA, aiming to improve early detection—particularly for women with dense breasts—and target reimbursement at roughly $350–$500 per test.